123 related articles for article (PubMed ID: 1356863)
1. Duration of acid suppression in H2-antagonist nonresponders.
Savarino V; Mela GS; Zentilin P; Cutela P; Mele MR; Celle G
Digestion; 1992; 51(4):185-92. PubMed ID: 1356863
[TBL] [Abstract][Full Text] [Related]
2. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
3. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
4. Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer.
Savarino V; Mela GS; Scalabrini P; Di Timoteo E; Magnolia MR; Celle G
Digestion; 1987; 37(2):103-9. PubMed ID: 3305114
[TBL] [Abstract][Full Text] [Related]
5. Prolonged gastric pH monitoring in responder and nonresponder duodenal ulcer patients: response to placebo and to H2-blocker administration.
Masoero G; Rossanino A; Arossa W; De la Pierre M
J Clin Gastroenterol; 1991 Jun; 13(3):291-5. PubMed ID: 1676715
[TBL] [Abstract][Full Text] [Related]
6. Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer disease.
Thomson AB
Hepatogastroenterology; 1990 Jul; 37 Suppl 1():18-28. PubMed ID: 1976583
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
[TBL] [Abstract][Full Text] [Related]
8. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
Hamilton MI; Sercombe J; Pounder RE
Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
[TBL] [Abstract][Full Text] [Related]
9. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G
J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
[TBL] [Abstract][Full Text] [Related]
10. Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine.
Fullarton GM; Macdonald AM; McColl KE
Aliment Pharmacol Ther; 1991 Aug; 5(4):391-8. PubMed ID: 1685675
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of oral famotidine and ranitidine on gastric volume and pH.
Dubin SA; Silverstein PI; Wakefield ML; Jense HG
Anesth Analg; 1989 Nov; 69(5):680-3. PubMed ID: 2572186
[No Abstract] [Full Text] [Related]
12. Reduction of gastric acidity with ranitidine or famotidine: early evening dosage is more effective than late evening dosage.
Bauerfeind P; Cilluffo T; Emde C; Fimmel C; Kohler W; Gasser T; Blum AL
Digestion; 1987; 37(4):217-22. PubMed ID: 2890546
[TBL] [Abstract][Full Text] [Related]
13. A single night-time dose of famotidine is equivalent to ranitidine in decreasing 24-hour gastric acidity in asymptomatic duodenal ulcer subjects.
Thomson AB; Pinchbeck BR; Kirdeikis J; Zuk L; Marriage B; Prat A
Aliment Pharmacol Ther; 1989 Apr; 3(2):199-210. PubMed ID: 2491470
[TBL] [Abstract][Full Text] [Related]
14. [Does nocturnal monitoring of gastric pH permit the prediction of therapeutic response in severe duodenal ulcer treated with ranitidine?].
Galmiche JP; Tranvouez JL; Denis P; N'Djitoyap C; Guillard JF; Lehur PA; Colin R
Gastroenterol Clin Biol; 1985; 9(8-9):583-9. PubMed ID: 4076717
[TBL] [Abstract][Full Text] [Related]
15. Gastric and esophageal acidity during continuous treatment with H2-antagonists in uncomplicated esophagitis.
Fiorucci S; Santucci L; Perrone E; Abbritti F; Morelli A
Scand J Gastroenterol; 1989 Aug; 24(6):671-7. PubMed ID: 2573143
[TBL] [Abstract][Full Text] [Related]
16. Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring.
Celle G; Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P
Scand J Gastroenterol; 1988 May; 23(4):385-90. PubMed ID: 2898167
[TBL] [Abstract][Full Text] [Related]
17. Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine.
Savarino V; Mela GS; Zentilin P; Cutela P; Vigneri S; Termini R; Di Mario F; Ferrana M; Malesci A; Belicchi M; Celle G
Fundam Clin Pharmacol; 1996; 10(3):304-8. PubMed ID: 8836705
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
[TBL] [Abstract][Full Text] [Related]
19. Twenty-four-hour intragastric pH-metry: H2-receptor antagonist restoration of nightly gastric spontaneous alkalinization in duodenal ulcer healing.
Bianco A; Cagossi M; Piraccini R; Greco AV
Riv Eur Sci Med Farmacol; 1992; 14(5):281-91. PubMed ID: 1364062
[TBL] [Abstract][Full Text] [Related]
20. Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study.
Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P; Celle G
Am J Gastroenterol; 1988 Sep; 83(9):917-22. PubMed ID: 2901220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
